Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces

• Published in: Biomaterials Vol. 30; no. 20; pp. 3390 - 3396
• Main Authors: Schwartz, Zvi, Olivares-Navarrete, Rene, Wieland, Marco, Cochran, David L, Boyan, Barbara D
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01-07-2009
• Subjects: Advanced Basic Science; Biocompatible Materials - chemistry; Biocompatible Materials - metabolism; Cell Culture Techniques; Cell Line; Dentistry; Humans; Integrin alpha2beta1 - genetics; Integrin alpha2beta1 - metabolism; Materials Testing; Microtopography; Osteoblast; Osteoblasts - cytology; Osteoblasts - metabolism; Osteoprotegerin; Osteoprotegerin - genetics; Osteoprotegerin - metabolism; Protein Kinase C - antagonists & inhibitors; Protein Kinase C - metabolism; Signal Transduction - physiology; Surface Properties; TGF-β1; Titanium; Titanium - chemistry; Titanium - metabolism; Transforming Growth Factor beta1 - metabolism; Microtopography; Osteoblast; Titanium; TGF-β1; Osteoprotegerin
• ISSN: 0142-9612; 1878-5905
• DOI: 10.1016/j.biomaterials.2009.03.047

Abstract Osteoblasts grown on microstructured Ti surfaces enhance osteointegration by producing local factors that regulate bone formation as well as bone remodeling, including the RANK ligand decoy receptor osteoprotegerin (OPG). The objective of this study was to explore the mechanism by which surface microstructure and surface energy mediate their stimulatory effects on OPG expression. Titanium disks were manufactured to present different surface morphologies: a smooth pretreatment surface (PT, Ra < 0.2 μm), microstructured sandblasted/acid etched surface (SLA, Ra = 3–4 μm), and a microstructured Ti plasma-sprayed surface (TPS, Ra = 4 μm). Human osteoblast-like MG63 cells were cultured on these substrates and the regulation of OPG production by TGF-β1, PKC, and α2β1 integrin signaling determined. Osteoblasts produced increased amounts of OPG as well as active and latent TGF-β1 and had increased PKC activity when grown on SLA and TPS. Exogenous TGF-β1 increased OPG production in a dose-dependent manner on all surfaces, and this was prevented by adding blocking antibody to the TGF-β type II receptor or by reducing TGF-β1 binding to the receptor by adding exogenous soluble type II receptor. The PKC inhibitor chelerythrine inhibited the production of OPG in a dose-dependent manner, but only in cultures on SLA and TPS. shRNA knockdown of α2 or a double knockdown of α2β1 also reduced OPG, as well as production of TGF-β1. These results indicate that substrate-dependent OPG production is regulated by TGF-β1, PKC, and α2β1 and suggest a mechanism by which α2β1 signaling increases PKC, resulting in TGF-β1 production and TGF-β1 then acts on its receptor to increase transcription of OPG.